133 related articles for article (PubMed ID: 22366990)
1. Transforming growth factor-β1-gene polymorphism in the development of kidney disease after liver transplantation.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Bahra M; Neuhaus P; Schmitz V
Transplantation; 2012 Mar; 93(5):555-60. PubMed ID: 22366990
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
4. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
5. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
6. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C
Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
[TBL] [Abstract][Full Text] [Related]
8. [Association between transforming growth factor beta-1 gene polymorphism and chronic allograft nephropathy].
Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; DU CF; Wang YB
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):535-7. PubMed ID: 17545053
[TBL] [Abstract][Full Text] [Related]
9. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
10. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
12. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Babel N; Vergopoulos A; Trappe RU; Oertel S; Hammer MH; Karaivanov S; Schneider N; Riess H; Papp-Vary M; Neuhaus R; Gondek LP; Volk HD; Reinke P
Transplantation; 2007 Aug; 84(3):387-91. PubMed ID: 17700165
[TBL] [Abstract][Full Text] [Related]
13. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 gene polymorphism in liver graft recipients.
Gómez-Mateo J; Marin L; López-Alvarez MR; Moya-Quiles MR; Miras M; Marin-Moreno I; Botella C; Parrilla P; Alvarez-López MR; Muro M
Transpl Immunol; 2006 Dec; 17(1):55-7. PubMed ID: 17157217
[TBL] [Abstract][Full Text] [Related]
15. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
[TBL] [Abstract][Full Text] [Related]
17. The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation.
van de Wetering J; Weimar CH; Balk AH; Roodnat JI; Holweg CT; Baan CC; van Domburg RT; Weimar W
Transplantation; 2006 Dec; 82(12):1744-8. PubMed ID: 17198270
[TBL] [Abstract][Full Text] [Related]
18. TT genotype of transforming growth factor beta1 +869C/T is associated with the development of chronic kidney disease after liver transplantation.
Cuenca AB; Citores MJ; de la Fuente S; Duca AM; Escamilla N; Baños I; Cuervas-Mons V
Transplant Proc; 2014 Nov; 46(9):3108-10. PubMed ID: 25420836
[TBL] [Abstract][Full Text] [Related]
19. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels.
Morard I; Mentha G; Spahr L; Majno P; Hadengue A; Huber O; Morel P; Giostra E
Clin Transplant; 2006; 20(1):96-101. PubMed ID: 16556162
[TBL] [Abstract][Full Text] [Related]
20. TGF-Beta codon 25 polymorphism and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation.
Rashidi-Nezhad A; Azimi C; Alimoghaddam K; Ghavamzadeh A; Hossein-Nezhad A; Izadi P; Sobhani M; Noori-Daloii AR; Noori-Daloii MR
Iran J Allergy Asthma Immunol; 2010 Mar; 9(1):1-6. PubMed ID: 20548127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
